Background. Skin pigmentation is a common problem for dialysis patients, but little is known about the factor responsible for the colour intensity. Middle-molecular-weight (MMW) substances have been suggested to be responsible for the skin colour. Several papers have reported that β 2 -microglobulin (β 2 -MG) correlates with the skin colour, and haemodiafiltration (HDF) is effective to reduce the skin hyperpigmentation. However, a quantitative skin colour follow-up on patients treated with online haemodiafiltration (online HDF) has not been performed. Methods. Sixty-one patients were enrolled in this study. Quantification of skin colour was done using a reflected light colorimeter. Among them, 51 patients were under haemodialysis (HD), and the other 10 patients were under online HDF. Follow-ups to estimate the skin colour change were performed for 6 months. Among 10 patients under online HDF, four patients were also investigated by crossover way between HD and online HDF. Results. Compared with controls, patients treated with HD had darker skin. The colour value was well correlated with age, haematocrit, sex, diabetes and β 2 -MG but not with Kt/V. The skin colour got worse under HD treatment as well as the values of β 2 -MG, but online HDF improved the hyperpigmentation and the β 2 -MG values. Conclusions. Our data show the effectiveness of online HDF on skin colour and suggest that HD patients' skin colour can be improved by modality change.
Introduction
Skin colour alterations are observed in patients with endstage renal disease (ESRD) [1] [2] [3] , and have been related to self-esteem and other psychological characteristics in patients [4, 5] . Therefore, skin pigmentation should be recognized as one of the major problems in ESRD patients. We have to find an effective therapy to relieve the skin pigmentation.
Previously, Lai et al. reported that by using a handheld reflected light colorimeter, dialysis patients develop darker skin colours than controls in the non-sun-exposed area. They have also shown that no difference of skin colour is found in haemodialysis (HD) patients with or without adequate Kt/V and in ESRD patients with HD or peritoneal dialysis (PD), while significantly lighter skin is detected in PD patients who have an adequate weekly creatinine clearance [6] . To our knowledge, it is the first report to quantify the skin colour alterations in patients with ESRD by an objective method in the last 10 years. However, they performed only a cross-sectional measurement of skin colour, and did not suggest which can be the main uraemic toxins to induce the skin colour alterations or what modality will be the good option to reduce the skin darkness in HD patients.
Lin et al. demonstrated an improvement in skin pigmentation in ESRD patients after the frequency of online haemodiafiltration (online HDF) had been increased, but they did not measure the colour by using objective methods [7] .
Moon et al. recently showed that HDF can improve the colour compared with low fluxed HD. Dialysis modality is the independent factor associated with decreases in the forehead melanin index. β 2 -microglobulin (β 2 -MG) reduction rate is correlated with skin colour change in HD and HDF therapy. Thus, they suggest that middle-molecular-weight (MMW) substances are responsible for the skin colour, and HDF improves the colour because of the removal of MMW proteins. However, they could show the difference in the sunexposed area and not in the non-sun-exposed area, and they did not measure the effect of online HDF [8] .
Therefore, in our study, we have measured Japanese skin colour darkness by using an objective and stable method, and accumulated the values of skin colour quantification and serum uraemic toxin concentration to analyse what molecular size toxin can be responsible for the skin colour. Furthermore, we performed online HDF to answer whether it can be the therapeutic option to manage the skin colour problem.
Materials and methods

Design and subjects
This study included 61 patients with maintenance dialysis at Koujukai Rehabilitation Hospital for at least 6 months. They were aged 24-93 years (mean, 60.9 ± 12.5 years). There were 42 men and 19 women. Duration of renal replacement therapy ranged from 5 to 299 months (6.46 ± 5.90 years). Twenty-one patients (34%) had diabetic mellitus. Informed consent was obtained from every patient involved. Dialysis modalities for patients at Koujukai Rehabilitation Hospital were HD and online HDF. Polysulphone or polyethersulphone dialysers were used according to clinical conditions. Online HDF was performed by the pre-dilution method. The dilution volume was 40 L/4 h/one session. Every patient received dialysis three times a week.
Patients were excluded if they had any of the following conditions: (i) use of potentially depigmenting and hyperpigmenting drugs within the last 3 months before the study; (ii) changes in dialysis modality within the last 6 months before study; (iii) presence of jaundice; (iv) average haematocrit <25%; (v) serum ferritin level >350 ng/mL; (vi) pre-existing skin disorder; (vii) presence of hepatitis B or C virus infection; (viii) a bright skin colour (L-value >70) which overlapped that of healthy controls; or (ix) recent hospitalization for any morbidity within last 3 months before the study.
Biochemical data were obtained at the start of the study (Baseline), the middle point and 6 months after the start (Follow-up). The data shown without any note were those taken at the middle point. Delivered singlepool Kt/V in the study month was recorded. Adequate Kt/V is defined as delivered single-pool Kt/V of 1.2 or greater.
Subjects who were scheduled to receive an adult health check-up from general community around the hospital during the same period and an estimated glomerular filtration rate [9] >60 mL/min were invited to serve as healthy controls for the study.
Measurement of skin colour
Skin colour was measured with a handheld reflected light colorimeter (CR-400, Konica Minolta, Tokyo, Japan). The colorimeter was re-calibrated against a standard white tile before each measurement. The abdomen skin 1 cm above the umbilicus was measured. Measurements were performed thrice just before the mid-week session for dialysis patients and during the health check-up for healthy controls, and the mean values were calculated. To minimize the influence of natural solar irradiation, all measurements were carried out indoors.
Skin colour was recorded by using the Commission Internationale de l'Eclalarge-recommende L*a*b system [6] . It is the most commonly used system for quantification of skin colour and has been used in the patients with many skin disorders [10] [11] [12] as well as patients with ESRD [13] . Briefly, in the system, skin colour is defined by its reflectance (L*) and chromaticity (a* and b*). The L* value indicates brightness ranging from black (L* = 0) to white (L* = 100). The a* value represents the balance between red and green, and b* value represents the balance between yellow and blue.
Statistical analysis
All values are expressed as mean ± SD. Statistical analysis was performed using SPSS for Windows version 13.0 (SPSS, Inc., Chicago, IL, USA). Results were analysed using paired t-tests or Mann-Whitney test. Independent factors associated with the skin colour in HD patients were determined by single and stepwise regression analysis with forward selection. Significance was defined by P <0.05.
Results
Demographic and clinical characteristics of HD patients and controls
Sixty-one patients undergoing haemodialysis were enrolled in this study. Among 61 patients, 51 were on HD.
This study included 137 control subjects. There was no significant difference in sex, age, serum total protein, and albumin values between controls and patients undergoing HD. A relatively smaller percentage of controls were suffered from diabetes mellitus, and controls had higher haematocrit values (Table 1) . We focused on L-values of abdomen (non-sun-exposed area), because it was reported that the patients with ESRD have the smaller (darker) Lvalues of abdomen and ESRD is an independent significant factor for the values [6] . Then, the HD patients had significantly darker skin colour compared with controls (L-value; 64.0 ± 4.7 and 66.7 ± 5.3, respectively; Figure 1 ).
The factors related to skin colours in patients undergoing HD
To examine predictors of skin colour in HD patients, single regression analysis was performed. The factors analysed were sex, age, diabetic mellitus, duration of dialysis therapy, haematocrit, α 1 -MG, β 2 -MG, creatinine, phosphate, albumin, intact parathyroid hormone, Kt/V and ferritin levels. Among them, we found that age, sex, diabetic mellitus, duration of dialysis therapy, albumin, β 2 -MG and haematocrit levels correlated with L colours (Table 2) . Women or diabetic patients have lighter colour. Younger patients have darker skin. If the duration of dialysis therapy is longer, the skin colour becomes darker. Lower albumin, lower β 2 -microglobulin and lower haematocrit levels correlate with lighter colour.
Next, we performed stepwise regression assay of the factors: age, sex, diabetic mellitus, duration of dialysis therapy, albumin, β 2 -MG, creatinine and haematocrit levels. Then, it revealed that sex, age, diabetic mellitus, haematocrit and β 2 -MG independently associated with the L colour (Table 3) .
Not HD but online HDF improved the L colour
We measured the L colour at 0 and 6 months later for patients with HD or online HDF. The comparison of clinical characteristics and laboratory findings between HD and online HDF patients are shown in Table 4 . The patients under online HDF were younger and had higher creatinine levels. At first, we found the skin colour was getting significantly darker in HD patients (L-value; Baseline 64.0 ± 4.7 and Follow-up 63.2 ± 4.8; Figure 2A) . In an inverse manner to the L-values, the β 2 -MG values were getting Figure 2B ), while haematocrit did not change in the study span (data not shown). Next, we divided HD patients with L-value-increasing group (n = 19) and decreasing one (n = 32). We compared the two groups and found that the L-value-increasing patients (whose skin colours were improved) had better Kt/V and lower β 2 -MG (Table 5) . According to the analysis of HD patients above, we hypothesized that the therapy to reduce the β 2 -MG level is the good option to control skin colour. Therefore, we performed online HDF to 10 patients. Their skin colour became lighter significantly after 6 months (Lvalue; Baseline 64.2 ± 4.1 and Follow-up 66.5 ± 4.1; Figure 3A ). Again, in an inverse manner to the L-values, the β 2 -MG values decreased significantly (β 2 -MG; Baseline 30.4 ± 4.2 and Follow-up 28.3 ± 4.0; Figure 3B ), while haematocrit did not change in the study span (data not shown). In addition, we were able to evaluate the skin colour using crossover methods between HD and online HDF in four patients. Online HDF was likely to improve the skin pigmentation and β 2 -MG concentration in patients who could not have improvement by HD.
Discussion
In this study, we were able to analyse the independent possible factors responsible for skin colour in HD patients, and online HDF could reduce skin hyperpigmentation.
We confirmed that our method to quantify the skin colour is appropriate by checking the colour darkness in controls and HD patients. Next, by analysing the clinical and laboratory data, we found MMW protein, and β 2 -MG is an independent possible factor associated with the skin colour. Finally, we examined online HDF effect to prove our hypothesis. Thus, we could show the new convincing data to prove the advantage of online HDF over HD.
We also examined the correlation between skin colour and small molecular protein (creatinine), or large-molecularweight protein (α 1 -MG). Neither creatinine nor Kt/V had association with the colour (Tables 2 and 3) , while the L-value-increasing group had better Kt/V and lower β 2 -MG (Table 5 ). Previous study reported that adequate Kt/V had no correlation with the skin colour in HD patients, but adequate weekly creatinine clearance had affected the skin colour in PD patients [6] . These data suggest that MMW molecules are more responsible for the skin colour than small molecules, because PD is more effective to remove MMW proteins than HD. α 1 -MG did not show the correlation, because HD cannot remove such large molecules. So it is still possible that large molecules can be partly responsible for the skin colour.
Several molecules, such as urochromic pigments, carotenoids, and α-and β-melanocyte-stimulating hormone, have been implicated in the pathogenesis of pigmentation in ESRD patients [14] [15] [16] [17] [18] . Our study can support the enhanced removal of MMW substances by convective therapy that can reduce skin hyperpigmentation (Figures 2  and 3 ). These data were reported by Moon et al. [8] , but the effectiveness of online HDF was unexplored. We could not have a large number of online HDF patients because of the insurance limitation in Japan. A large sample study about online HDF effect on the skin colour, especially crossover study with HD, will be needed in the future. Not only our data but also the accumulation of the proof to show the advantage of online HDF will affect the Japanese insurance system. We also found that diabetic patients had brighter skin colour. Insulin resistance in non-diabetic peritoneal dialysis patients can affect the skin redness and yellowness [19] but not brightness. It suggests that insulin may affect the skin colour. Leptin can be one more candidate to explain the diabetic patients skin colour because insulin and leptin are the upstream molecules of α-melanocyte-stimulating hormone [20] [21] [22] . In addition, leptin can be removed by HDF [23] . We will focus on the skin colour and these hormone concentrations in diabetic patients in further study.
In conclusion, thinking of the previous reports, the skin colour of patients under haemodialysis can be determined by many factors. It is pretty difficult to decide the most influential molecule to the skin colour. However, we definitely found that the enhancement of convective clearance is the best option to manage the skin colour of patients under haemodialysis now. . Six months later, the skin colour became lighter, and the values of β 2 -MG became lower significantly in online HDF patients (n = 10). Two HD patients changed the modality from HD to online HDF. Other two online HDF patients changed the modality from online HDF to HD. Online HDF was likely to improve the skin colour and the β 2 -MG concentration of patients which were resistant to HD therapy. All the lengths of the arms are 6 months. 
